By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Capricor Therapeutics, Inc. 

8700 Beverly Boulevard
Davis Building - Room D-1063
Los Angeles  California  90048  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Capricor Therapeutics, Inc. Announces Favorable ALLSTAR Phase I Safety Results 11/18/2014 11:51:10 AM
Capricor Therapeutics, Inc. Reports Third Quarter 2014 Financial & Business Highlights 11/12/2014 8:05:29 AM
Capricor Therapeutics, Inc. To Hold Duchenne Muscular Dystrophy Data Presentation Call On November 18, 2014 At 9:30 A.M. ET 11/7/2014 12:13:58 PM
Capricor Therapeutics, Inc. To Hold Third Quarter 2014 Business Update Conference Call On November 12, 2014 At 4:30 P.M. ET 10/31/2014 7:41:21 AM
Capricor Therapeutics, Inc. Announces Acquisition Of Intellectual Property Rights To Family Of Natriuretic Peptides From Medtronic, Inc. (MDT) 10/14/2014 7:13:45 AM
Capricor Therapeutics, Inc. Announces Plans To Pursue A Cenderitide Clinical Program And Enters Into Research Support Agreement With Insulet Corporation (PODD) 10/9/2014 8:10:58 AM
Capricor Therapeutics, Inc. Announces Plans To Pursue Clinical Program For The Treatment Of Duchenne Muscular Dystrophy With Cardiosphere-Derived Cells (CDCs) 10/6/2014 7:25:48 AM
Capricor Therapeutics, Inc. Presents Safety And Preliminary Efficacy Results From ALLSTAR Phase I Clinical Trial At TCT 2014 9/18/2014 7:47:07 AM
Capricor Therapeutics, Inc. Reports Second Quarter 2014 Financial & Business Highlights 8/13/2014 12:32:26 PM
Capricor Therapeutics, Inc. To Hold Second Quarter 2014 Business Update Conference Call On August 13, 2014 At 4:30 P.M. Eastern Time 8/4/2014 8:21:03 AM
123
//-->